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I. LIST OF ABBREVIATIONS 
BCAA   branched-chain amino acids 
BOP   bleeding on probing 
CAL   clinical attachment level 
CAL 3+mm%  percentage of sites with CAL ≥3 mm  
CAL 4+mm%  percentage of sites with CAL ≥4 mm 
CEJ   cementoenamel junction 
cumPPD4+  cumulative PPD from pockets with PPD ≥4 mm 
DF-S   total number of decayed, filled tooth surfaces  
DF-S%   percentage of decayed or filled tooth surfaces 
FDR   false discovery rate 
GCF   gingival crevicular fluid 
IL   interleukin 
LC-MS   liquid chromatography - mass spectrometry 
Mean CAL  mean clinical attachment level over all sites 
Mean PPD  mean periodontal probing depth over all sites 
MS   mass spectrometry 
MT count  total number of missing teeth 
NMR    nuclear magnetic resonance 
PG   prostaglandin 
PPD   periodontal probing depth 
PPD 3+mm%  percentage of sites with PPD ≥3 mm 
PPD 4+mm%  percentage of sites with PPD ≥4 mm 
Prosthesis/MT determinate variable referring to removable denture and tooth loss 
ROS   reactive oxidative species 
rP   Pearson correlation coefficient 
SHIP   Study of Health in Pomerania 






Periodontitis, also called gum disease, is an infectious inflammation of the periodontium. The 
periodontium consists of the gingiva, the cementum of the root, the periodontal ligamentum 
and the alveolar bone (Figure 1). It has mechanical supportive and protective functions and 
enables each tooth to stay fixed in its alveolar pocket. Sensory, nutritive, formative and 





The prevalence increases with age, so mostly adults at the age of 40 to 60 are affected, but in 
rare cases it manifests in children and younger adults too. In 2010 severe periodontitis 
occurred with a prevalence of 11.2% worldwide and was thus the sixth-most prevalent 
condition among all diseases of the human body in the world [1]. Consequently periodontitis 
is understood as a troublesome global burden [2]. 
 
 





Periodontitis is a plaque-induced, persistent gingival inflammation modulated by individual`s 
host immune-inflammatory response [3]. The onset, the severity and the progression of 
periodontitis is strongly influenced by intrinsic and extrinsic risk factors [4]. These include 
immune modulating genetic or systemic disorders, medication, age, sex, stress, diet, 
consumption of alcohol, smoking and local factors such as tooth crowding, insufficient dental 
fillings and restorations [5-9]. 
Risk factors according to Beck [10] 
1. Oral factors (micro flora, saliva, dental deformations, fillings, prosthesis) 
2. Socio-demographic factors (age, sex, income, education) 
3. Behavioural factors (smoking, oral hygiene) 
4. Physical and medical factors (poorly controlled diabetes mellitus, systemic diseases, 
drugs, physical disability) 
5. Psychological and environmental factors (dental awareness, social support) 
6. Immunological factors (acquired or innate immune deficits) 
ETIOLOGY AND PATHOGENESIS 
ORAL BIOFILM FORMATION 
Onset and development of periodontitis requires the presence of periodontal pathogens 
within a highly organized biofilm. The oral biofilm is a composition of different bacteria 
embedded in an extracellular matrix of polymers of host and bacterial origin, mainly 
exopolysaccharide-polymers produced by the microorganisms themselves [11]. Within the 
biofilm bacteria establish a community that communicates via small, diffusible signalling 
molecules (“quorum sensing”), optimizes the exchange of nutriments, provides protection 
against antibacterial substances (e.g. antibiotics, salivary lysozyme or immunoglobulin A) and 
even supports the exchange of beneficial genes in order to improve and strengthen bacterial 
survival. 
First step in biofilm formation is the development of the acquired pellicle, a conditioning film 
of salivary glycoproteins that forms on the tooth surface right after cleaning. Afterwards 
pioneer germs like actinomycetes can accumulate to the pellicle using fimbriae, pili and 
adhesins [12]. The biofilm grows through bacterial cell proliferation, co-adhesion and co-
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aggregation of further bacteria and secretion of extracellular polymers forming a complex 




Figure 2: Modified schematic representation of oral biofilm formation, inspired by Jaroch 




ORAL BIOFILM AND PERIODONTAL INFLAMMATION 
In the initial state of periodontal disease adherent bacteria in the supragingival plaque 
produce enzymes like bacterial collagenases, hyaluronidases, proteases and peptidases to 
disintegrate the periodontal tissue. They also release metabolites like short-chain fatty acids 
(butyrate, propionate) and chemo-active peptides like N-formyl-methionyl-leucyl-
phenylalanine and lipopolysaccharides (Endotoxin). As reaction to these toxic products 
activated host tissue macrophages liberate pro-inflammatory mediators like interleukins (IL-
1, IL-6, IL-8) and tumour necrosis factor alpha (TNF-α) and produce proteases and 
prostaglandins (PG). IL-8 is responsible for chemotactic recruitment of more 
polymorphonuclear leukocytes. Host defence causes an acute inflammatory reaction 
including vasodilatation, an elevated vascular permeability, which is responsible for 
oedematous swelling and reddening of gingiva without attachment loss, and activation of 
sensible nerve  endings, the production of acute-phase-proteins and it stimulates the 
phagocytosis of bacteria [5]. This mild state of periodontal disease is called gingivitis.   
 
Without intervention and persistent inflammation, the junctional epithelium might tear at its 
base and pathological gingival pockets are formed. Bacteria are enabled to roam into a deeper, 
subgingival level. The enhanced flow of protein-rich gingival crevicular fluid (GCF) offers a new 
source of nourishment for bacteria. The microbial composition starts to shift from aerobic, 
saccharolytic and gram-positive to anaerobic, low saccharolytic or asaccharolytic, protein 
fermenting, gram-negative and more pathogenic bacteria [13]. Investigations revealed that 
specific groups of bacteria in the subgingival plaque, the so-called periopathogenic germs, are 
primarily associated with the onset of periodontitis [14, 15]. Those bacteria can be divided 





















Bacterial colonization of subgingival areas takes place successively and individually for each 
subject. Establishment and progression of periodontitis is determined by common occurrence 
and interaction between those specific bacterial groups. 
Especially bacteria of the “red complex” Porphyromonas gingivalis, Tannerella forsythensis 
and Treponema denticola are linked to disease progression of periodontitis [18]. 
Host immune cells attempt to overcome the microbial burden thereby  releasing cytokines, 
chemokines, proteases, prostaglandins and other inflammatory mediators [19]. Established 
periodontal lesions progress into deeper periodontal pockets with extended soft tissue 
destruction and alveolar bone.  IL-1, TNF-α and PGE2 stimulate polynuclear osteoclasts [5] in 
proliferation, differentiation and secretion of bone dissolving proteolytic enzymes. 
Additionally, osteoblasts function is inhibited. Both host and bacterial proteases lead to 
protein degradation and the loss of periodontal ligament. As part of host defence against 
bacteria immune cells produce reactive oxygen species (ROS), a variety of molecules and free 
radicals able to deal significant damage to cell structures. Host tissues are able to avoid 
damage by ROS using anti-oxidative substances (e.g. glutathione, ascorbic acid and uric acid).  




If there is a lack of anti-oxidants, the oxidative burst harms host tissue structures in collateral 
as well [20, 21]. This non-reversible, destructive state of disease is called periodontitis. The 
loss of attachment is a discontinuous process during progress of periodontitis. The changes of 
exacerbation and remission indicates the interaction between host and periopathogenic 
bacteria [22].  
Host-bacteria interaction, cell and tissue destruction generate organic substrates like proteins, 
cell components, nucleic acid fragments or other small molecules. 
 
MANIFESTATION AND CONSEQUENCES 
First symptoms of gingival inflammation as part of gingivitis are gingival bleeding, increased 
sensibility and an elevated production of gingival crevicular fluid [23]. Severe periodontitis 
stages are characterized by periodontal tissue destruction, halitosis, alveolar bone resorption, 
loosening of teeth and finally tooth loss if left untreated [9, 16, 24] (Figure 4). In worst case 
the patient becomes edentulous. This directly affects the quality of life of people in terms of 
reduced functional capacity like chewing, biting or speaking. A more extended tooth loss often 
requires a partial or complete denture, which reduces aesthetics, self-confidence and social 
relationships. Psychological alternations in self-image associated with shame, guilt and loss of 
attraction and vitality are also consequences [25]. 
 
  





Furthermore, chronic periodontitis has been linked to increased inflammation in the body, 
such as indicated by raised levels of C-reactive protein and IL-6 [26-28]. Previous research 
revealed potential associations between periodontitis and other systemic diseases (Figure 5) 
like arteriosclerosis [29], chronic cardiovascular problems [27, 30], respiratory diseases [31], 
rheumatoid arthritis [32], chronic kidney disease [33], liver disease [34] and adverse 
pregnancy outcomes [35, 36]. 
In addition, periodontitis might influence metabolic control in patients with diabetes mellitus, 
so that they have difficulties with balancing their blood glucose level owing to the constantly 
elevated systemic inflammatory state caused by the periodontal inflammation. In return 
diabetes mellitus (type 1 or type 2), especially a poorly controlled, is one of the most important 












DIAGNOSIS AND THERAPY 
Although periodontitis is one of the most common chronic inflammatory diseases of the 
human body [1, 9] there is no valid clinical test that detects regions of high disease activity 
and prospectively predicts periodontal tissue destruction. Usually dentists identify 
periodontitis by visual inspection of gingival tissue and alveolar bone status (X-ray), specific 
signals of inflammation like bleeding on probing (BOP) and increased periodontal pocket 
depths. In rare cases samples from periodontal pockets can be microbiologically analysed to 
identify specific disease-associated bacteria. Traditional periodontal clinical criteria, however, 
are often insufficient to determine periodontal active sites and quantitatively to monitor  
individual therapy response or to provide information about possible future susceptibility of 
disease progression [38]. Dependent on the clinical status the periodontal therapy consists of 
standard anti-infectious procedures like oral health education, removal of calculus and 
plaque, subgingival scaling and eventually surgical interventions [9]. 
 
Often periodontitis is too late recognized in an advanced state. Standard therapy can help to 
stop disease progression and supports tissue reparation processes, but without laborious 
intervention a full recovery of the supportive tissue is impossible [9]. So, there is an urgent 
need for an easy, non-invasive method to detect disease activity in earlier stages to allow 
intervention prior to disease onset or progression. This could reduce periodontitis prevalence, 
slow its progression and prevent its (potentially) related complications. Newly generated 
knowledge revealed genetic, microbiological and immunological mechanisms as the driver of 
periodontitis. This progress could actually change the present ‘reactive’ therapeutic point of 





Metabolomics is the scientific and systematic study of biochemical processes and pathways 
within cells, biofluids, tissues or organisms involving small substrates, intermediates and 
products of host and microbial metabolism, the metabolites, which can be influenced by 
genetic and environmental factors [40]. It is one of the most complex methods of life science 
considering the high number and diversity of metabolites and their different physicochemical 
properties. Due to the divergent nature of small molecules no technique alone is able to 
measure the entire metabolome at once and many different complementary techniques 
evolved during the last decades to determine the small molecule content of bio specimens, 
most importantly nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry 
(MS). The latter are often coupled with chromatographically methods (liquid chromatography- 
mass spectrometry (LC-MS), gas chromatography-mass spectrometry, capillary 
electrophoresis-mass spectrometry) to increase resolution [41]. The main focus lies on the 
comprehensive study of biochemical mechanism and interaction of the human body [42]. 
Metabolomics is based on the idea that biological fluids like blood, plasma, urine, lymph or 
saliva reflect the health of an individual and can be used for medical analysis and diagnosis to 
identify disease and disease states [43]. The metabolomics approach is an important tool in 
biomedical research, which contributes to the identification of new potential biomarkers [44].  
Biomarkers are accurately and reproducibly measurable and evaluable products of the 
organism which refer to a person’s individual health status [45]. For medical purposes a high 
number of diagnostic and predictive biomarkers are already used for example specific 
metabolites linked to various diseases, such as cardiovascular disease [30, 46, 47], cancer [48-
50], diabetes [51] and Morbus Parkinson [52]. 
A number of studies already applied metabolomics approaches to the investigation of oral 
health-related questions. To capture local events inside the oral cavity bio fluids such as saliva 
or gingival crevicular fluid (GCF) have been the predominant source for metabolomics 
profiling.   
Saliva and GCF contain plenty of inflammation-associated metabolites which are produced 
from tissue breakdown, increased vascular permeability, microbial and host cellular 
metabolism. These metabolites within the body fluids may help to understand the complex 
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biochemical processes and host-bacteria interactions which lead to periodontitis and offer 
potential biomarkers reflecting the severity of periodontal inflammation [53]. 
 
2.3. ORAL BIOFLUIDS 
 SALIVA 
Saliva is a clear, watery biofluid assembled by secretions from the three major salivary glands 
(Gl. submandibularis, Gl. sublingualis, Gl. parotidea) (Figure 6) and diffusely distributive minor 




In addition, GCF and amounts of expectorated nasal and bronchial secretions are part of saliva. 
Saliva mainly contains water (>99%) and minor components like mucus, digestive enzymes, 
proteins, growth factors, cytokines, immunoglobulins, antibacterial peptides, bacteria, cell 
fragments, salts and low molecular weight metabolites [54, 55]. The biochemical composition 
is highly influenced by physiological or pathological states, medication, stimuli, insults and 
stressors [56, 57]. Salivary function extends from oral cavity lubrication to physical tissue 




protection, remineralization of tooth enamel, anti-oxidative [58, 59] and microbiological 
defence, wound healing [60, 61] and pain relief [62]. It further enables swallowing, tasting, 
speaking and food digestion [63]. The mean daily salivary secretion is about 0.5 -1.5 litre [64]. 
The physiological pH of saliva is about 6.2 to 7.4 (slightly acidic to basic) [65]. 
Saliva collection is fast, easy, often repeatable, non-invasive and low priced [66]. It is more 
comfortable, less painful and less frightening for patients since there is no need for using 
needles. The risk of percutaneous injury, infection and contagion is completely avoided.  
Saliva, often termed as “mirror of the body” [67, 68], is able to reflect the physical and  
pathological condition of the human body, therefore saliva as a biofluid can be applied in 
biomarker research for both oral and systemic diseases [66, 69]. Previous studies 
demonstrated that saliva can be used in diagnostics of several cancer types (oral squamous 
cell cancer [70], pancreatic cancer[71], gastric cancer[72]), infectious bacterial (H. pylori [73, 
74], shigella [75]), fungal (candidiasis [76]) and viral diseases (hepatitis [77, 78], herpes, HIV 
[79], measles, mumps, and rubella [80]), autoimmune diseases (Sjögren´s syndrome [81], 
cystic fibrosis [82-84]), metabolic diseases (obesity [85, 86], diabetes mellitus [87, 88]) and 
dental diseases (periodontitis [89-92], caries risk valuation[93, 94]). 
 
GINGIVAL CREVICULAR FLUID 
Gingival crevicular fluid (GCF) is a blood serum transudate of dentogingival vessels which 
enters the gingival sulcus through the sulcular pocket and junctional epithelium. It cleanses 
the crevice, possesses antimicrobial properties and exerts antibody defence.  The physical 
flow of GCF is increased by tissue inflammation and increased vascular permeability, factors 
which are directly connected to periodontitis. The fluid is composed of plasma components 
and locally produced constituents like tissue breakdown products, inflammatory mediators, 
fragments of host or bacteria cells and microbial metabolites [95]. Sample collection of GCF is 
more difficult compared to saliva. Micro litre volumes rising up from the periodontal pocket 
make sampling times longer especially in healthy subjects. Samples are also susceptible for 




2.4. OVERVIEW ON PREVIOUS RESEARCH 
Previous studies that performed metabolomic profiling of saliva and GCF (Table 1) already 
revealed important results [20, 96-98] which demanded further research. They reported 
significant alterations in purine degradation [96, 97] and fatty acid metabolism in response to 
a changed redox status and chronic inflammation at periodontitis sites [20]. The purine 
degradation pathway, as a major biochemical source for host ROS production, was higher at 
periodontally diseased sites compared to healthy sites.  An increased production of ROS leads 
to oxidative stress (condition resulting from an imbalance between the excessive formation 
of ROS and limited antioxidant defences). Cellular anti-oxidants like glutathione, ascorbic acid 
and uric acid play a key role in cellular defence against free radicals and counteract ROS 
reducing the oxidative stress level. Consequently there are lower concentrations of anti-
oxidants in diseased sites of the periodontium [96] and an increased glutathione metabolism 
in parallel with increased levels of oxidized glutathione [97]. The imbalance of ROS and anti-
oxidants contributes to higher oxidative stress levels and tissue damage. Increased levels of 
redox active metal ions including Mn, Cu, Zn and elevated levels of salivary isoprostanes, 
which are formed from free radical catalysed peroxidation of fatty acids, are also signals for 
oxidative stress caused by complex host-bacteria-interaction exacerbated during the 
periodontal destruction. Dietary interventions aiming to restore redox balance might provide 
a possibility to reduce periodontitis risk [20]. 
Using metabolomic profiling of saliva from healthy and periodontitis patients [98], a number 
of metabolites (dipeptides, amino acid, carbohydrate, lipids, nucleotide metabolites) were 
found to be differentially present. The authors suggested that these changes indicate 
increased macromolecular degradation of proteins, triacylglycerol, glycerophospholipids, 
polysaccharides, and polynucleotides in periodontitis patients. They further deduced that the 
periodontitis specific shift in enzyme activity “generated a more favourable energy 
environment for oral bacteria, potentially exacerbating the disease state” [98]. Another study 
investigated the profile of bacterial-specific volatile metabolites produced by typical 
periodontal pathogens like Aggregatibacter actinomycetemcomitans, Porphyromonas 
gingivalis, Tannerella forsythia and Treponema denticola [99].  
While this highlights the potential of metabolites to serve as new biomarkers for periodontitis, 
it was emphasized that larger cohorts should be analysed to validate previous results.
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Table 1: Summary of previous studies on saliva metabolome in association to periodontitis 
Study Author Year Biofluid Metabolites /Pathways Association 
Global Metabolomic Analysis of Human 
Saliva and Plasma from Healthy and 
Diabetic Subjects, with and without 
Periodontal Disease [97] 
 
N=161 (80 diabetic, 81 healthy) 
Barnes et al. 2014 Saliva 
Plasma 
Purine Degradation ↑ 
Dipeptides ↑ 
Amino Acid Metabolites ↑ 
Carbohydrates ↑ 
DNA/RNA Degradation ↑ 
ω-6 fatty acids ↑ 












Acceleration of Purine Degradation by 
Periodontal Disease [96] 
 
N=22 
Barnes et al.  2009 GCF Anti-oxidants (glutathione) ↓ 
Tri- and di-saccharides↓ 
Amino acids ↑ 
Choline glycerophosphate ↑ 
Polyamines ↑ 
Purine degradation ↑ 




Cell membrane degradation 
Amino acid degradation 
Oxidative stress 
Protein degradation 
Metabolomics Reveals Elevated 
Macromolecular Degradation in Periodontal 
Disease [98] 
 
N=68 (34 periodontitis, 34 healthy) 
Barnes et al. 2011 Saliva Dipeptides ↑ 
Amino acids ↑ 
Carbohydrates ↑ 
Lipids ↑ 











Prediction of Periodontal Inflammation via 
Metabolic Profiling of Saliva [53] 
 
N=19 














Amino acid degradation 




Continued Table 1 
Mass spectrometry-based metabolomic 
profiling identifies alterations in salivary 
redox status and fatty acid metabolism in 
response to inflammation and oxidative 
stress in periodontal disease [20] 
 
N=100 (50 periodontitis, 50 healthy) 
 
Huang et al. 2014 Saliva 
Blood 
Redox active metal-ions ↓ 






Using NMR in saliva to identify possible 
biomarkers of glioblastoma and chronic 
periodontitis [100] 
 
N=130 (39 periodontal healthy, 59 











Amino acid degradation 
Amino acid degradation 




Metabolomic analysis of gingival crevicular 
fluid using gas chromatography/mass 
Spectrometry [101] 
 
N=30 (14 chronic periodontitis, 16 healthy) 
 










Saliva diagnostics -Current views and 










Fatty acid metabolism 
Ratio of Pro-Resolving and Pro-
Inflammatory Lipid Mediator Precursors as 
Potential Markers for Aggressive 
Periodontitis [103] 
 
N=28 (14 aggressive periodontitis, 12 
healthy) 
 
Elabdeen et al.  
 





Continued Table 1 




Dame et al. 2015 Saliva Short chain fatty acids 
Amino acids 






Distinct signatures of dental plaque 
metabolic byproducts dictated by 
periodontal inflammatory status [105] 
 
N=50 (10 healthy, 28 moderate 
periodontitis, 12 severe periodontits) 
 





Amino acid degradation 
Metabolomic analysis of saliva reveals 
generalized chronic periodontitis signature 
[106] 
 
N=54 (22 healthy, 32 peridontitis) 
 
Aimetti et al.  
 









The dental calculus metabolome in modern 
and historic samples [107] 
 
N=17 (5 fresh, 12 historic) 
Velsko et al.  
 















Identification of a discriminative 
metabolomic fingerprint of potential clinical 
relevance in saliva of patients with 
periodontitis using 1H nuclear magnetic 
resonance (NMR) spectroscopy [108] 
 
N=51 (26 periodontitis, 25 healthy) 
 
Rzeznik et al.  
 






Analysis of salivary phenotypes of 
generalized aggressive and chronic 
periodontitis through nuclear magnetic 
resonance-based metabolomics. [109] 
 
N=100 (33 chronic periodontitis, 28 
aggressive periodontitis, 39 healthy) 
Romano et al. 2018 Saliva Pyruvate ↓ 














Continued Table 1      
Lipid peroxidation levels and total oxidant 
status in serum, saliva and gingival 
crevicular fluid in patients with chronic 
periodontitis. [110] 
 
N=83 (48 periodontitis, 35 healthy) 
 




Malondialdehyde (MDA) ↑ 
Total oxidant status ↑ 
Oxidative stress 
Salivary malondialdehyde levels in clinically 
healthy and periodontal diseased 
individuals.[111] 
 
N=104 (30 healthy, 74 periodontitis) 
Khalili, Biloklytska 2008 Saliva Malondialdehyde (MDA) ↑ Oxidative stress 
Lipid peroxidation: a possible role in the 
induction and progression of chronic 
periodontitis [112] 
 
N=22 (13 periodontitis, 9 healthy) 
 





Glutathione (GSH) ↓ 




Lipid peroxidation and antioxidant activity 
in saliva of periodontitis patients: effect of 
smoking and periodontal treatment [113] 
 
N=60 (30 healthy, 30 periodontitis) 
 






Total antioxidant capacity ↓ 




Lipid peroxidation levels, total oxidant 
status and superperoxide dismutase in 
serum, saliva and gingival crevicular fluid in 
chronic periodontitis patients before and 
after periodontal therapy [114] 
 
N=83 (48 periodontitis, 35 healthy) 
 






Total oxidant status↑ 












Continued Table 1      
Detection of periodontopathic bacteria and 
oxidative stress marker in saliva from 
periodontitis patients [115] 
 
N=49 (20 healthy, 29 periodontitis) 
 
















Oxidative DNA damage 
Antioxidative status of saliva before and 





Novaković et al.  
 
2013 Saliva Glutathione peroxidase activity ↓ Oxidative stress 
Salivary biomarkers: Relationship between 
oxidative stress and alveolar bone loss in 
chronic periodontitis [117] 
 
N=40 (20 periodontitis, 20 healthy) 
Miricescu et al.  2013 Saliva 8-hydroxydeoxyguanosine ↑ 
Malondialdehyde (MDA) ↑ 
Glutathione peroxidase activity ↓ 
Total antioxidative capacity ↓ 
Oxidative DNA damage 
Oxidative stress 
DNA: deoxyribonucleic acid, RNA: ribonucleic acid, GCF: gingival crevicular fluid, COX: cyclooxygenase, NMR: nuclear magnetic resonance, ↑ elevated/ increased/ high level, ↓ reduced/ 





Metabolomics profiling has become a powerful tool for disease characterization and 
biomarker discovery [95]. Until now, only few metabolites were identified as potential 
biomarkers of periodontal inflammation which may be helpful to detect the periodontal 
inflammation and to monitor periodontal treatment [53]. However, all previous studies 
suffered from small sample sizes limiting statistical power in detecting any new biomarkers 
after correction for multiple testing, and the lack of an appropriately large replication cohorts. 
Thus, there is a huge demand for large-scale population-based studies evaluating potential 
biomarkers for periodontitis using saliva metabolomics data. 
Therefore, our study aimed to improve the current knowledge of the metabolomic profile of 
periodontitis to discover associations between the clinical periodontal phenotype and the 
saliva metabolome of a large number of individuals using different laboratory methods. We 
aimed to associate metabolic profiles with periodontitis phenotypes. We wanted to gain more 
information about the interrelation between the clinical symptoms of periodontitis, bacteria-
host interactions and to elucidate pathways which lead to changed metabolite presence or 
concentration. This could offer the opportunity to develop laboratory-based periodontal 
diagnostic biomarkers for clinical monitoring and early recognition of periodontitis. 
2.6. HYPOTHESIS 
1. The human saliva metabolome is significantly changed in subjects with periodontal disease 
depending on disease severity compared to healthy individuals.  
2. Those differences are associated with altered bacterial metabolism, inflammation and local 
periodontal tissue destruction. 
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III. MATERIALS AND METHODS 
The materials and methods used in this study are described in detail by Liebsch et al. within 
the published article [118]. In the following sections some aspects, not covered in the article 
are reported in more detail. 
3.1. STUDY POPULATION / SHIP 
The Study of Health in Pomerania “Life and health in western Pomerania” (SHIP) is a 
population-based cohort study of the rural north-east part of Germany (West Pomerania) 
[119] (Figure 7). The prospective surveys provide a unique database throughout Germany and 
give important information about causal correlation between incidence and prevalence of 
diseases and their risk factors.  
SHIP-0 was the first cohort study, which examinations were conducted between 1997 and 
2001. The independent second baseline study (SHIP-Trend-0) was conducted between 2008 
and 2012, including 4420 participants aged 20-83 years (50.1% response). Stratification 
variables were age, sex and city/ county of residence. All participants gave written informed 
consent before taking part in the study. The study was approved by the ethics committee of 
the University of Greifswald and conformed to the principles of the declaration of Helsinki. 
 
  
Figure 7: Map of the SHIP study region (former borders of districts Greifswald, Stralsund 




Examinations comprised a computer-aided health-related interview, an oral health 
examination, a medical examination, and a health- and risk factor-related questionnaire. The 
general medical examination includes measurements of body index and blood pressure; the 
evaluation of an electrocardiography and an echocardiography; a sonography of the carotid 
artery, the thyroid and the liver; a neurological screening and analysis of blood and urine 
samples. The computer-aided health related interview includes questions to generate socio-
demographically and socio-economically data. In addition, the claims for medical help, the 
health-related behaviour and special questions to cardiovascular symptoms were queried. The 
health- and risk factor-related questionnaire was filled out independently by the subjects. It 
includes questions to life and work conditions, consume of alcohol and tobacco, the individual 
social network and the own subjective state of health.  
Oral health examinations were performed on 4322 from 4420 participants. The survey of 
dental data comprises an interview, the investigation of oral mucosa and denture status, 
elevation of periodontal and orthodontic data and a functional analysis. No periodontal 
examinations were done for 409 subjects, further 237 subjects were edentulous in the 
examined site and for additional 56 subjects’ periodontal inspections were either refused or 
not recordable because of medical reasons leaving 3620 subjects with periodontal probing 
depth data. Further, clinical attachment loss could not be determined in 189 subjects mainly 
due to oral restorations (crowns, fillings) resulting in 3431 subjects with available attachment 
values.  
For a specific SHIP-TREND sub-sample that encompasses 1000 participants without self-
reported diabetes (type 1 or type 2) a more extensive phenotyping was performed including 
e.g. additional laboratory measurements and metabolome analyses of saliva, urine and 
plasma. After exclusion of edentulous subjects and individuals with missing values in either 





3.3. DENTAL VARIABLES 
Periodontal status was assessed by means of clinical attachment level (CAL), periodontal 
probing depth (PPD), calculus, plaque, bleeding on probing (BOP) and the number of teeth. 
Third molars found no consideration. CAL and PPD were measured at four sites per tooth 
(mesiobuccal, midbuccal, distobuccal, midpalatinal/ midlingual) according to the half-mouth 
method (measurements in only 2 quadrants, left or right side randomly selected) excluding 
third molars. A 1mm-scaled periodontal probe was used (PCP-15, Hu-Friedy, Chicago, IL, USA). 
PPD was measured as the distance between free gingival margin and the pocket base (Figure 
8). CAL equals the distance between the cementoenamel junction (CEJ) and the pocket base 
(Figure 8). If the CEJ was visible, CAL and PPD were measured directly, otherwise the distance 
between the gingival margin and CEJ was subtracted from PPD, which equalled CAL. Where 
the determination of the CEJ was indistinct (e.g. wedge-shaped defects, fillings or crown 
margins), CAL was not recorded. Measurements were mathematically rounded to the nearest 
millimetre. Calculus and plaque (present/ absent) were assessed in the upper and lower jaw 
on four sites on three teeth (first and third incisor, first molar) after periodontal probing. If 
teeth were missing, the next distally located tooth was considered. If this one was missing too, 
no value was raised. Present teeth, filled or decayed surfaces (DF-S) were counted excluding 
third molars. In the additional dental questionnaire, it was queried whether a removable 









3.4. SALIVA METABOLOME 
Stimulated saliva was collected with a commercially available hygienic collection system 
(Salivette®, Sarstedt, Nümbrecht, Germany) (Figure 9) under special conditions mentioned by 











Figure 9: Saliva collection system using a cotton role 
 
Figure 10: Simplified illustration of saliva sampling, processing and analysis; 1. Saliva 
sampling with Salivette® collection system; 2. Centrifugation right after sampling; 3. 
Freezing for storage; 4. Transport to analysis centre (Helmholtz Zentrum München); 5. 
Saliva sample is divided and one sample was pipetted and 6. put into 96 well plate; 7. 
Adding of methanol for protein precipitation; 8. Centrifugation; 9. Supernatant splitted into 
4 subsamples; 10. Two subsamples were taken for analysis, two subsamples stored as 
reserve; 11. Sample desiccation using TurboVap 96; 12. Adding formic acid in one 
subsample (positive mode LC-MS/MS) and ammonium bicarbonate in the other subsample 
(negative mode LC-MS/MS); 13. LC-MS/MS in positive and negative ionization mode; 14. 




3.5. PLASMA METABOLOME 
To investigate whether the discovered saliva metabolites originated from local metabolism in 
the oral cavity or from the plasma, we used additional plasma metabolome data which was 
obtained from the same SHIP-Trend subjects at the same day. Fasting plasma samples were 
collected between 07:00 and 12:00 am. The blood samples were taken from the cubital vein 
in a supine position and stored at -80°C. Samples were processed and analysed at the Genome 
Analysis Centre, Helmholtz Zentrum, Munich, exactly using the same procedure that was used 




The main results of the study on the saliva metabolome in association to oral health status are 
presented in the article published by Liebsch and colleagues in April 2019 [118]. Further results 
according to the additional investigations on plasma metabolome are described in the 
following sections. 
4.1. PLASMA METABOLITES ASSOCIATED TO ORAL HEALTH STATUS 
A total of 20 plasma metabolites showed significant associations to at least one of the 
following dental parameters under investigation: calculus, plaque, Mean CAL, PPD4+mm%, 
cumPPD4+, Mean PPD. No significant hit could be found for DF-S%, DF-S, Prosthesis/MT, MT 
count, CAL 4+mm%, CAL 3+mm% and PPD3 + mm% (Figure 11). Seventeen metabolites 
matched known structures in our reference data, while 3 metabolites remained unknown 
(termed with X-number). A total of five metabolites were positively associated with our dental 
variables, fifteen showed inverse associations. 
Plasma caffeine along with the unknown metabolite X-1140 was positively associated with 
calculus. Twelve of the thirteen plaque-associated metabolites were inversely associated 
including indolepropionate, various phosphatidylcholines and sphingomyelins, the amino acid 
derivate N-acetylcarnosine and two unknown metabolites (X-02249, X-11315). Only L-urobilin, 
a degradation product of haemoglobin, was positively associated. The amino acid tryptophan 
was inversely associated with mean CAL. Both creatine and glutamate showed a moderate 
positive association with PPD- and CAL-related variables. Significant positive associations were 
found between creatine and PPD 4mm+% and cumPPD4+ while glutamate was significantly 
positively associated with PPD4mm+% and MeanPPD. Glutamine, methionine, SM (OH) C14:1 
and N-acetylcarnosine showed an inverse directional trend to PPD4mm+%, cumPPD4+ and 
Mean PPD. None of the significant plasma metabolites directly corresponded to those found 












Figure 11: Heatmap of significant associated plasma metabolites to at least one of the traits 
under investigation. Color coding indicates positive (orange) or negative associations 
(blue), thereby the intensity represents the level of significance after controlling the false 
discovery rate (FDR). Edged box indicates an FDR<0.05, representing the chosen 
significance threshold. Metabolites were grouped by functional entities. 
Variables: percentage of decayed or filled tooth surfaces (DF-S%), total number of filled or 
decayed tooth surfaces (DF-S), percentage of sites with visible, supragingival mineralized 
plaque (Calculus), percentage of sites with visible, supragingival plaque (Plaque), total 
number of missing teeth (MT count), percentage of sites with CAL ≥3/4 mm (CAL 3+mm% 
and CAL 4+mm%), mean CAL over all sites (Mean CAL), percentage of sites with PPD ≥4 
mm/ 3 mm (PPD 3+mm% and PPD 4+mm%), cumulative PPD from pockets ≥4mm 
(cumPPD4+), mean PPD over all sites (Mean PPD), prosthesis/missing teeth as comparison 
of group 1 (no prosthesis, 0-8 missing teeth) and group 3 (prosthesis, 9-27 missing teeth) 
(Prosthesis/MT). 
 PC ae = phosphatidylcholine with acyl-alkyl residue; PC aa = phosphatidylcholine with 





4.2.  PEARSON CORRELATION OF SALIVA AND PLASMA METABOLITES 
 
Out of all metabolites measured  
in saliva, corresponding plasma  
levels were available for 96 
metabolites (Figure 12). None of  
the salivary metabolite levels  
strongly associated with  
PPD-related variables were  
substantially correlated (rP>0.2)  


















Figure 12: Pearson correlation coefficients between metabolites measured in saliva and 
plasma from the SHIP-Trend subsample. Metabolites were grouped by functional entities. 
Black bars highlight saliva metabolites which were significantly associated with at least one 





Table 2: Pearson correlation coefficients of saliva and plasma metabolites 





















































































































X - 11381 
glucose, fructose, mannose, 
galactose, allose, altrose, etc. 
isobutyrylcarnitine 
pseudouridine 
X - 12128 















dihomo-linolenate (20:3n3 or n6) 
p-cresol sulfate 
X - 14465 




13-HODE + 9-HODE 
X - 12748 
X - 16103 
X - 16394 
N1-Methyl-2-pyridone- 
5-carboxamide 






































































0.03037      
rP: Pearson correlation coefficients; X= unknown structure 
Upper and lower case indicate the platform used to measure those metabolites. Lower case indicates metabolites measured using 
Metabolon (same platform as saliva) whereas upper case indicates Biocrates p180 Kit (a targeted MS approach which was done for the 
same samples: Some of the metabolites measured in saliva were not available for plasma Metabolon and hence we used Biocrates 




5.1. DISCUSSION OF SALIVA METABOLITES ASSOCIATED TO AT LEAST 
ONE TRAIT UNDER INVESTIGATION 
Within the published article from Liebsch et. al (2019) the associations between the salivary 
metabolome and oral health status were analysed and extensively discussed. 
In general, the associated biological saliva metabolites are surrogates of tissue breakdown 
(decomposition of biomembranes, proteinic structures, fats and nucleic acids) (Figure 13), 
beta-oxidation, pH regulation and several host defence mechanisms (ROS production, 
production of pro inflammatory mediators, anti-oxidative defence) (Figure 14). 
 









The metabolites originate from oral bacteria (within the supragingival/subgingival plaque) or 
from host metabolism. Some of our dental health-associated saliva metabolites are 
demonstrably transferred from plasma (e.g. creatine, 1,5-anhydroglucitol) while associated 
xenobiotics show presumable connections to cigarette or alcohol consumption and oral 
hygiene behaviour. All general information about the salivary metabolites, their associations 
and the supposed context are summarized in the following table 3.
Figure 14: Defense mechanism of the host due to bacterial burden in periodontitis, 
abbreviations: SCFA= short-chain fatty acids; ROS = reactive oxygen species; ILs= 




Table 3: Summarized information about saliva metabolites associated to at least one periodontal trait under investigation 





Amino acid, proteinogenic, 
non-essential 






(-) MT count - Associations found in group age 60+ (older people have averaged less teeth 
than younger people) 
- Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein decomposition due to anaerobic bacteria 
→ Reduction of amino acid (e.g. aspartate) liberation into saliva 
Creatine Amino acid derivate 
(derived from glycine, 
arginine and 
adenosylmethionine) 
Endogenous biosynthesis (liver) 
 
Food intake (esp. meat, fish) 
(+) MT count - Creatine occurs in all human beings (primarily in muscle tissue) and is involved 
in energy supply for muscle contraction 
- Creatine is synthesized in the liver and transported via blood (plasma) 
- As saliva composition interrelates with plasma composition [120], creatine 
levels in saliva are associated to plasma levels 
- Plasma levels of creatine elevated due to chronic kidney diseases (CKD)[120]  
→ maybe salivary levels of creatine elevated due to kidney diseases as well 




Amino acid derivate 
(derived from glutamic 
acid) 
Endogenous metabolism of 
glutathione (host) 
(+) Calculus - 5-oxoproline is formed during the utilization of glutathione [122] 
- Glutathione is an intracellular reductant (possesses antioxidative properties) 
→ defends cellular structures from harm by ROS like free radicals, peroxides 
- ROS mainly produced by mitochondria and immune cells  
- ROS production via immune cells elevated as part of host defence against 
bacterial infection 
→ ROS damage bacteria cell structures 
→ ROS cause collateral damage to host tissue as well 
- Endogenous antioxidants like glutathione neutralize ROS 
→ consumption/ utilization of glutathione 
→ enhanced formation of 5-oxoproline 
→ progressive reduction of antioxidants in cases of sustained microbial burden 
leads to oxidative stress [96] 
- 5-oxoproline was found as potential biomarker for periodontitis [53] 
Glutathione 
(y-glutamyl-cysteinyl-glycine) 
Tripeptide Naturally occurring endogenous 
antioxidant (host) 
(+) PPD 3mm+% - Reducing agent 
- Practice antioxidative defence against ROS 
→ protects host cell structures 
- Supports the maintaining of other antioxidants in their active, reduced form 
(vitamin C, vitamin E) 
- ROS produced by host immune cells as part of defence against bacterial burden 
(periodontitis) can harm the host tissue as well 
- Antioxidants offer protection against ROS 
→ consumption of glutathione  
→ reduced salivary levels 
- Imbalance between ROS and antioxidants cause oxidative stress 
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- Oxidative stress is association to periodontitis is observed in multiple previous 
metabolomic analysis of saliva or GCF [20, 96, 97, 116, 117, 123, 124] 
Threonine Amino acid, proteinogenic, 
essential 
Degradation of endogenous 
proteinic structures (peptides, 
proteins) 
 
Decomposition of exogenous 




- Threonine is an important component of many proteins (e.g. collagen, elastin, 
tooth enamel) 
→ collagen found within alveolar bone and connective tissue of the periodontal 
apparatus 
 
- Periodontopathogenic, proteolytic, anaerobic bacteria degenerate proteinic 
structures of the host using bacterial proteases 
- Bacteria also induce host immune response including activation of immune cells 
→ production of proteolytic host enzymes (MMP-8, MMP-9, elastase, 
aminopeptidase), TNF-α, IL-6, IL-2 and other cytokines in order to destroy 
bacteria 
→ collateral degeneration of connective collagen and alveolar bone [95] 
- Liberation of amino acids like threonine 
- Acids produced by several bacteria favour chemical enamel dissolution  
(-) MT count - Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein decomposition due to anaerobic bacteria 
→ Reduction of amino acid (e.g. threonine) liberation into saliva 
- The less teeth > the less enamel dissolution due to bacteria 
Imidazole propionate 
(imidazole propionic acid) 
Amino acid derivate 
(derived from 
proteinogenic, semi-
essential, aromatic, amino 
acid histidine) 
 
Imidazolyl carboxylic acids 
Catabolism of amino acid 
histidine (bacteria) 
 
(+) Plaque - Imidazole propionate originates from bacterial histidine catabolism [125] 
- Dental plaque comprises a huge amount of bacteria 
- Advanced plaque is marked by a shift of microbial composition( from aerobic, 
saccharolytic to anaerobic, low saccharolytic or asaccharolytic, protein 
fermenting, bacteria [13] 
→ more bacterial catabolism of available amino acids (e.g. histidine) 
→ elevated imidazole propionate levels 
Trans-urocanate Amino acid derivate 
(derived from 
proteinogenic, semi-
essential, aromatic, amino 
acid histidine) 
 
Imidazolyl carboxylic acids 
Catabolism of amino acid 
histidine (bacteria) 
(-) MT count - Associations found in group age 60+ (older people have averaged less teeth 
than younger people) 
- Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 




Amino acid derivate 
(derived from BCAA 
isoleucine) 
Catabolism of BCAA isoleucine 
(bacteria) 
(-) MT count 
(-) Prosthesis/MT 
- Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→Reduction of amino acid catabolites (e.g. 3-methyl-2-oxovalerate) liberation 
into saliva 
- In cases of multiple tooth loss, a denture is required 
4-methyl-2-oxopentanoate 
(4-methyl-2-oxopentanoic acid) 
Amino acid derivate 
(derived from BCAAs) 
Catabolism of BCAAs (bacteria) (-) MT count 
(-) DF-S% 
- Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
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→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→Reduction of amino acid catabolites (e.g. 4-methyl-2-oxopentanoate) 
liberation into saliva 
Alpha-hydroxyisocaproate 
(leucinic acid) 
Amino acid derivate 
(derived from BCAA 
leucine) 
Catabolism of BCAA leucine 
(bacteria) 
(+) Plaque - BCAA leucine is metabolized by bacteria to alpha-hydroxyisocaptoate (e.g. by 
Lactobacillus species [126] and Eubacterium brachy [127], both microbial 
components of dental plaque)[128] 
Isoleucine BCAA, essential, 
proteinogenic 
Degradation of endogenous 
proteinic structures (peptides, 
proteins) 
 
Decomposition of exogenous 
proteinic structures (originating 
from food) 
(-) MT count - Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→Reduction of amino acid (e.g. isoleucine) liberation into saliva 
- Corresponding to that conclusion: salivary levels of isoleucine are increased in 
samples of individuals of with moderate/ severe periodontitis as result of 
enhanced protein degradation by amino acid fermenting bacteria [100] 
Isovalerate Short-chain fatty acid 
(SCFAs) 
Catabolism of BCAA valine, 
leucine, isoleucine (bacteria) 
(+) Mean PPD 
(+) CumPPD4+ 
(+) PPD 4+mm% 
(+) Plaque 
- BCAA catabolism provides energy for bacteria 
- Pathway found in periodontal pathogenic P. gingivalis, P. intermedia, 
Eubayterium brachy [127] 
- Increased levels found in saliva samples of individuals with moderate / severe 
periodontitis [100] 
- SCFAs favouring junctional epithelium degeneration processes by stimulating 
inflammation response and cytokine liberation [100, 129, 130] 
→ Simplified entry for bacteria and periodontal pocket formation 
Leucine BCAA, essential, 
proteinogenic 
Degradation of endogenous 
proteinic structures (peptides, 
proteins) 
 
Decomposition of exogenous 
proteinic structures (originating 
from food) 
(-) MT count - Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→Reduction of amino acid (e.g. leucine, valine) liberation into saliva 
 




Fatty acid (pentanoic acid 
with an amino substituent 
at C-5) 
Degradation product of amino 
acid lysine (bacteria) 
(+) Mean PPD 
(+) CumPPD4+ 
(+) PPD 4+mm% 
(+) PPD 3+mm% 
(+) Plaque 
- Bacteria catabolize lysine to cadaverine (foul smelling diamine responsible for 
oral malodour) 
- Cadaverine is catabolized to 5-aminovalerate 
- Lysine catabolites are associated with putrefaction 
- Associations with high periodontal inflamed surface areas 
- Metabolite levels elevated in GCF samples of deep pockets 
Lysine Amino acid, essential, 
proteinogenic 
Degradation of endogenous 
proteinic structures (peptides, 
proteins) 
 
Decomposition of exogenous 
proteinic structures (originating 
from food) 
(-) MT count - Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→Reduction of amino acid (e.g. lysine) liberation into saliva 
- Corresponding to that conclusion: amounts of lysine and its catabolites higher 
in oral fluid samples of periodontal ill compared to healthy individuals [53, 101, 
105, 131] 
N6-acetyllysine Amino acid, 
posttranslational modified 
proteinogenic structures within 
eukaryotic cells, esp. core histone 
(+) Mean PPD  
(+) CumPPD4+  
- Host cell destruction due to pathogenic bacteria 
- Degradation of proteinaceous structures 
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(acetylation of amino acid 
lysine) 
proteins inside the nucleus and 
cytosolic proteins regulating 
cellular metabolic functions 
(host) 
(+) PPD 4mm%  
(+) Plaque 
→ Increased liberation of N6-acetyllysine into saliva results from increased 





Degradation product of amino 
acid lysine (bacteria) 
(+) Mean PPD 
(+) CumPPD4+ 
(+) PPD 4+mm% 
(+) PPD 3+mm% 
(+) Plaque 
- Bacteria catabolize lysine to pipecolate 
- Pipecolic acid is an important component or precursor of many bacterial 









acids (phenol substituted 
short-chain fatty acids 
(SCFA)) 
Metabolic products of aromatic 
amino acid (e.g. phenylalanine, 
tyrosine) fermentation by 
anaerobes)[132, 133] (bacteria) 
(+) Mean PPD  
(+) CumPPD4+  
(+) PPD 4+mm%  
(+) PPD 3+mm%  
(+) Plaque  
 
- Metabolites originate from amino acid fermentation 
- Metabolites associated to periodontitis and periodontal pathogenic bacteria 
metabolism[127] 
- 3-phenylpropionate (hydrocinnamate) was proposed as potential biomarker 
for periodontal inflammation [53] 
- 3-phenylpropionate associated with high periodontal inflamed surface areas 
[105] 
Phenylalanine Amino acid, proteinogenic 
essential, aromatic 
Degradation of endogenous 
proteinic structures (peptides, 
proteins) 
 
Decomposition of exogenous 
proteinic structures (originating 
from food) 
(-) MT count - Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→Reduction of amino acid (e.g. lysine) liberation into saliva 
(+) Plaque - Advanced plaque is marked by a shift of microbial composition( from aerobic, 
saccharolytic to anaerobic, low saccharolytic or asaccharolytic, protein 
fermenting, bacteria [13] 
→ more bacterial catabolism of available proteins, peptides 
→ elevated phenylalanine levels 
- Concentrations of phenylalanine higher in GCF and saliva samples of individuals 
moderate/ severe periodontitis [101, 106] as result of protein degradation 
caused by bacteria and host proteases 
Tyrosine Amino acid, proteinogenic, 
aromatic, non-essential 




Endogenous biosynthesis  
(anabolism) 
(-) MT count - Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→Reduction of amino acid (e.g. tyrosine) liberation into saliva 
Tryptophan Amino acid, proteinogenic, 
aromatic, essential 
Degradation of endogenous 
proteinic structures (peptides, 
proteins) 
 
Decomposition of exogenous 
proteinic structures (originating 
from food) 
(+) cumPPD4+ 
(+) PPD 3mm+% 
- Host cell destruction due to periodontal pathogenic bacteria 
- Degradation of proteinaceous structures 
→ Increased liberation of tryptophan into saliva results from increased 
protease activity (host, bacteria) 
Arginine Amino acid, proteinogenic Degradation of endogenous or 
exogenous proteins (catabolism) 
 
(-) MT count - Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
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Endogenous biosynthesis within 
urea cycle (anabolism) 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→ Reduction of amino acid (e.g. arginine) liberation into saliva 
Citrulline Amino acid, non-
proteinogenic, non-
essential 
Intermediate product of urea 
cycle (host) 
 
Amino acid arginine catabolism 
[134] (bacteria) 
(-) MT count 
(-) DFS-% 
- Citrulline is a major product of arginine and ornithine catabolism 
- Fermentation of arginine is performed by oral bacteria (e.g. S. sanguis, S. mitis, 
Streptococcus gordonii, Lactobacillus, Actinomyces) 
- Citrulline counters sugar metabolism-based acidification (regulates salivary pH) 
and therefore offers protection to acid-sensitive bacteria [127, 135] 
- Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) and decrease of attachment 
possibilities (less formation of dental plaque) 
    → Reduced protein and amino acid decomposition due to anaerobic bacteria 
    → Reduction of amino acid (e.g. citrulline) liberation into saliva 
 
- plain surfaces in cases of dental crowns and fillings (e.g. ceramics, non-
precious/ precious metal alloys, amalgams) offer less attachment possibilities 
for bacteria 
    → less plaque/ bacteria → less arginine catabolism to citrulline 
N-delta-acetylornithine Amino acid, non-
proteinogenic 
Biosynthesis of ornithine, 
arginine and polyamines 
(bacteria) 
(+) Plaque - Prokaryotes receive ornithine from amino acid glutamine via intermediate N-
delta-acetylornithine 
- Ornithine is precursor for amino acid arginine and for polyamines 
- Polyamines are involved in DNA replication and cell division 
- Elevated saliva levels are associated with bacterial metabolism, cell growth 
and cell proliferation  [136] 
Proline Amino acid, proteinogenic, 
non-essential 
Degradation of endogenous or 
exogenous proteins (catabolism) 
Endogenous biosynthesis 
(anabolism) 
(-) MT count 
(-) DF-S% 
- Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein and amino acid decomposition due to anaerobic bacteria 
→ Reduction of amino acid (e.g. proline) liberation into saliva 
 
- Plain surfaces in cases of dental crowns and fillings (e.g. ceramics, non-
precious/ precious metal alloys, amalgams) offer less attachment possibilities 
for bacteria  
→ less plaque 
→ less protein/ peptide fermenting bacteria 
Trans-4-hydroxyproline Amino acid, 
posttranslational modified 
(hydroxylation of amino 
acid proline), non-essential 
Proteinic structures within 
eukaryotic cells, e.g. collagen, 
elastin (host) 
(+) MT count 
(+) DF-S% 
- Trans-4-hydroxyproline is a major component of collagen 
- It contributes to the stability of the collagen triple helix 
- Its content in biological fluids is used as a parameter of collagen catabolism, 
especially bone resorption or tissue degradation 
- Teeth loss often requires partial or total prosthesis, which shore up on oral 
mucosa 
→ during mastication denture exert pressure to oral mucosa 
→ repeatedly mechanical pressure leads to degeneration of alveolar bone and 
exert damage to oral mucosa 
 
- Overhang and /or for hygiene inadequate designed fillings support 
accumulation of bacteria 
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- Bacteria of supra/subgingival plaque exert damage to oral tissue 
- Host immune response to bacterial metabolism products goes with enhances 
ROS production 
- ROS harm host tissue as well as bacteria 
→ elevated soft/ hard tissue destruction 
→ elevated decomposition of collagen 
→ elevated salivary levels of Trans-4-hydroxyproline 
Urea Diamide, carbonyldiamine Urea cycle, natural compound of 
saliva (host) 
(-) Plaque - Ureolytic bacteria of supragingival plaque metabolize urea to ammonia and 
carbonic acid 
- Ammonia neutralize acids (generated from sugar fermentation) to protect 
acid-sensitive bacteria 
1,5-anhydroglucitol (1,5 AG) Carbohydrate, 1-deoxy 
form of glucose 
Mainly Exogenous (diet) 
 
Rare endogenous (de-novo 
synthesis) 
(+) MT count - 1,5 AG is used for diabetes monitoring 
- High correlation between 1,5 AG concentrations in saliva and in plasma [137] 
    → 1,5 AG in saliva originates from plasma (translated by passive diffusion or via 
GCF) 
- 1,5 AG and glucose compete for renal reabsorption via specific glucose 
transporter (SGLT4)[138] 
- 1,5 AG plasma level decreased during periods of hyperglycaemia [138, 139] 
- Elevated plasma/saliva levels of 1,5 AG may result from increased renal 
reabsorption in cases of low glucose levels 
    → no competitive inhibition of urinary reabsorption by glucose 
- Low glucose plasma levels → sign of hypoglycaemia 
- Unknown context 
Lactate 
(lactic acid) 
Monocarboxylic acid Sugar metabolism (bacteria) (+) MT count - Association found within group age 60+ 
- Tooth loss is a sign of age and/or bad oral hygiene 
- Insufficient, irregular oral hygiene leads to increased amounts of oral bacteria 
- Older people often suffer under dry mouth/ xerostomia (low salivary flow rate 
caused by multiple factors) 
    → lack of saliva enables proliferation of oral microorganism 
- Tooth loss often requires partial or total dentures, which offer microorganisms 
surface for accumulation and biofilm formation  
- Oral bacteria metabolize sugar (e.g. glucose) to lactic acid 
Nicotinate 
(nicotinic acid, niacin) 
Vitamin Endogenous biosynthesis, 
Exogenous (diet) (host) 
(-) MT count - Essential metabolite for biosynthesis of coenzymes NAD and NADP 
→ involved in redox reactions (energy production in mitochondria, catabolism 
of fats/ sugars/ proteins) 
- Strongest association found within group age 60+ 
→ Older people often suffer from vitamin deficiency due to malnutrition 
Phosphate Electrolyte Natural compound of saliva (host) (-) Plaque - Bacteria of supragingival plaque (e.g. actinomyces, lactobacillus) are 
presumed to consume phosphate  
- Bacteria synthesize and store phosphate as polymer (polyphosphate) 
- Possible reason for subsequently reduced phosphate levels in saliva of 
individuals with high plaque score 
Malate 
(malic acid) 
Dicarboxylic acid Endogenous (intermediate in  
tricarboxylic acid cycle (TAC)), 
 
(+) MT count - Mitochondrial aging (reduced energy supply) is partly responsible for general 
aging processes in human 
- Associations to MT count were the strongest in individuals age 60+ 
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Exogenous (diet of several fruits) 
(host) 




Dicarboxylic acid Endogenous (key intermediate in 
the tricarboxylic acid cycle, a 
primary metabolic pathway used 
to provide energy) 





Amino acid derivate Endogenous (fatty acid 
metabolism) 
(+) MT count 
(+) DF-S% 
(+) Prosthesis/ MT 
- Carnitine is an essential cofactor for fatty acid metabolism within mitochondria 
- Found elevated in saliva samples of individuals with periodontitis [97, 98] 
Isocaproate 
(isocaproic acid) 
Short-chain fatty acid 
(SCFAs) 
Bacteria 
(catabolism of BCAA leucine) 
(+) Mean PPD 
(+) CumPPD4+ 
(+) PPD 4+mm% 
(+) PPD 3+mm% 
(+) Plaque 
- Leucine catabolism provides energy for bacteria 
- Pathway found in periodontal pathogenic Eubacterium brachy 
- Increased levels found in saliva samples of individuals with moderate / severe 
periodontitis 
- SCFAs favouring junctional epithelium degeneration processes by stimulating 
inflammation response and cytokine liberation (ref) 
→ Simplified entry for bacteria and periodontal pocket formation 
2-hydroxyglutarate 
(2-OHG) 
Fatty acid Metabolism of amino acid 
glutamate (bacteria) 
(+) Plaque - Dental plaque consists of amounts of oral bacteria 




Dicarboxylic acids Endogenous (metabolism of fatty 
acids) 
 
Exogenous, medicine (topical 
treatment of dermal diseases like 
acne and rosacea) 
 
Exogenous, plasticizers 
(+) MT count - Azelate is used as plasticizers [141] 
- Plasticizers are used in dental materials for soft relining [142] like 
polyvinylchloride, acrylic acid derivates 
- Soft relining is performed if the denture of a patient is lacking on adhesion or 
stability 
- The plasticizers within the soft relining materials detach from the denture 
material in time 
    → liberation into saliva 
Docosadioate 22:2 n-6 
(docosadienoic acid) 
Long-chain 
polyunsaturated fatty acid 
(PUFA), ω-6 fatty acid 
Host  
(metabolism of arachidonic acid) 
(+) cumPPD4+ - Docosadienoic acid is precursor to arachidonic acid (AA) 
- AA is output product for biosynthesis of pro-inflammatory eicosanoids 
(prostaglandins, thromboxane, leukotrienes) 
- AA derived prostaglandins and leukotrienes are associated with destruction of 
collagen and bone resorption occurring in periodontitis  
- PGE2 levels elevated in oral fluids of patients with periodontitis (responsible for 
inflammation, vasodilatation, enhanced pain perception, cytokine production 
and stimulation of bone resorption)   
- ω-6 fatty acid metabolism elevated in GCF and saliva samples of individuals with 
chronic or aggressive periodontitis [97, 102, 103] 
10-hydroxydecanoic acid Hydroxy fatty acid Exogenous (+) DF-S% - Hydroxy fatty acids are used for the synthesis of resins, nylons, polyurethanes, 
plastics, lubricants, biopolymers, and soaps 
- The polymers synthesized from hydroxy fatty acids have some advantages: 
higher resistance to heat, chemicals, and impact, more flexibility, higher 
biocompatibility, and no toxicity 
- Hydroxy fatty acids have been used as additives for the manufacture of 
plasticizers, emulsifiers, stabilizers [143] 




Hydroxy fatty acid Endogenous (mevalonate 
pathway that produces terpenes 
and steroids) 
 







- Higher salivary levels may associate to oral fillings (DF-S%) and plastic dentures 
(as therapy for multiple tooth loss (MT count)) 
Glycerophosphorylcholine (GPC) Choline derivative, 
phospholipid 
Endogenous (breakdown product 
of biomembranes) 
(+) MT count 
(+) Prosthesis/MT 
- GPC occurs during catabolism of phosphatidylcholine (PtC), a major component 
of biological membranes 
- Elevated GPC levels have been associated with tissue breakdown in 
periodontitis [96, 98, 106] 
- Enhanced degradation of PtC to choline via GPC as intermediate was found in 
saliva samples of individuals with moderate/severe periodontitis [100] 
- Tooth loss often requires compensation using dentures 
- Dentures rest on oral mucosa and exert mechanical stress during mastication 
to soft tissue 
→ thereby causing damage to superficial cells of the oral mucosa → cell 
decomposition including degradation of biomembranes 
- Insufficient hygiene of dentures allows attachment on bacteria and biofilm 
formation similar to tooth plaque responsible for periodontitis 
→ bacterial burden leads to inflammation and soft tissue degeneration as well 
Dihomo-linolenate 20:3 n-6 
(dihomo-linoleic acid) 
Long-chain 
polyunsaturated fatty acid 
(PUFA), ω-6 fatty acid  
Host  
(metabolism of arachidonic acid) 
(+) cumPPD4+ 
(-) MT count 
- Dihomo-linolenic acid is precursor to arachidonic acid (AA) 
- AA is output product for biosynthesis of pro-inflammatory eicosanoids 
(prostaglandins, thromboxane, leukotrienes) 
- AA derived prostaglandins and leukotrienes are associated with destruction of 
collagen and bone resorption occurring in periodontitis  
- PGE2 levels elevated in oral fluids of patients with periodontitis (responsible for 
inflammation, vasodilatation, enhanced pain perception, cytokine production 
and stimulation of bone resorption)   
- ω-6 fatty acid metabolism elevated in GCF and saliva samples of individuals with 
chronic or aggressive periodontitis [97, 102, 103] 
Hypoxanthine Purine Host 
(Endogenous catabolism purines 
of purine nucleosides adenosine 
and inosine) 
 
(+) cumPPD4+ - Hypoxanthine is an intermediate in purine catabolism (degradation of 
adenosine and inosine) and part of the endogenous purine salvage pathway 
- Hypoxanthine metabolism is a major source for ROS production by host 
immune cells 
- ROS production is part of host immune defence against microorganism 
- High amounts of ROS and low antioxidative defence leads to oxidative stress 
- ROS damage host cells as well as bacteria and supports tissue destruction 
- Purine degradation pathway was found accelerated/ upregulated in 
periodontitis [96] 
- Elevated salivary levels of hypoxanthine could also result from tissue 
destruction associated breakdown of nucleic acids (DNA, RNA) in periodontitis 
Inosine Purine, Nucleoside Host (catabolism of purines and 
purine nucleoside adenosine, de-
novo synthesis) 
(+) DF-S% - Intermediate in purine metabolism (precursor of hypoxanthine in catabolic 
pathway of purines) 
- DF-S% reflects current and/or past caries experience 
- Caries results from insufficient, irregular oral hygiene 
→ proliferation of oral bacteria 
- Acceleration of purine degradation pathway as part of host defence against 
bacterial burden 
- Microorganisms cause damage to host cells 
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→ inosine may liberate by breakdown of nucleic acids 
Adenine Purine base Host (catabolism of purine 
nucleotides ATP, ADP, AMP, 
cAMP and purine nucleoside 
adenine) 
(-) cumPPD4+ 
(-) PPD 4mm+% 
- Adenine originate from purine catabolism 
- Acceleration of purine degradation pathway was found in moderate/severe 
periodontitis [96] 
- Reduction of adenine containing substances in periodontitis [144] 
- Purine degradation pathway through xanthine oxidase is a major source for ROS 
production in PMNs (part of host immune defence against microorganisms) 
- ROS burst exert collateral damage to host tissue cells and supports tissue 
destruction in periodontitis 
Adenosine 5`-monophosphate (AMP) Purine nucleotide Host  
degradation of nucleic acids 
DNA/RNA 
Metabolism of purine nucleotides 
ATP, ADP, cAMP 
(+) MT count unknown 
 
Guanosine Purine, Nucleoside Host (catabolism of purine 
nucleotides GMP, GDP, GTP) 
(+) DF-S% - Intermediate in purine metabolism 
- Guanosine is further catabolized to xanthine  
- DF-S% reflects current and/or past caries experience 
- Caries results from insufficient, irregular oral hygiene 
→ proliferation of oral bacteria 
- Acceleration of purine degradation pathway as part of host defence against 
bacterial burden 
- Microorganisms cause damage to host cells 
→ guanosine may liberate by breakdown of nucleic acids 
2´-deoxycytidine 5´-monophosphate 
(dCMP) 
Pyrimidine, nucleotide Host (pyrimidine metabolism, 
part of nucleic acid DNA) 
(+) Mean PPD 
(+) cumPPD4+% 
(+) PPD 4mm+% 
 
- dCMP is compound of nucleic acid DNA 
- DNA degradation is caused by cell damage due to bacteria 
→ elevated levels of DNA fragment dCMP 
- In periodontitis macromolecular degradation increases including nucleic acid 
(e.g. DNA) decomposition [96] 
Cytidine Pyrimidine nucleoside Host (pyrimidine metabolism, 
pyrimidine salvage pathway) 
(-) cumPPD4+ 
(+) MT count 
unknown 
Thymidine Pyrimidine nucleoside Host (pyrimidine metabolism) (-) MT count unknown 
Uracil Pyrimidine base Host (pyrimidine metabolism) 
biosynthesis of pyrimidine 
ribonucleoside (uridine) and 
ribonucleotides (UMP, UDP, UTP) 
intermediate in pyrimidine 
nucleotide degeneration 






Dipeptides  Protein degradation (endogenous 
proteinic structures, exogenous 
proteins from diet) 
endogenous proteinbiosynthesis 
(+) cumPPD4+ - Elevated salivary levels of dipeptides in periodontitis are markers for tissue 
breakdown caused by proteolytic host enzymes (MMPs, elastases and 
aminopeptidases) and bacterial proteases [145] 
- Especially proteolytic bacteria of the subgingival plaque (e.g. Porphyromonas 
gingivalis [127]) use dipeptides and amino acids as nourishment 
- In order to overcome the bacterial burden in periodontitis proteolytic enzymes 
and cytokines are liberated by host immune cells 
→ MMPs, TNF-α, IL-1, IL-6 etc. 
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→ collateral damage to host tissue, degradation of connective soft tissue and 
alveolar bone [95] 
Prolylglycine Dipeptide Protein degradation (endogenous 
proteinic structures, exogenous 
proteins from diet) 
Endogenous Proteinbiosynthesis 
(-) MT count - Reduction of number of teeth accompanied with decrease of subgingival niche 
(less living space with anaerobic conditions) 
→ Reduction of the amount of anaerobic, protein fermenting bacteria 
→ Reduced protein decomposition due to anaerobic bacteria 
→ Reduction of dipeptide (e.g. Prolylglycine) liberation into saliva 
Cis, cis-muconic acid Unsaturated dicarboxylic 
acid 
Microbial production (+) MT count - Derived from benzene, toluene, benzoic acid, or catechol 
- Benzene are carcinogenic  ingredients of tobacco [146] 
- Smoking is one of the most important risk factors for periodontitis and 
increases risk of tooth loss 
Lauryl sulfate Xenobiotic, anionic tensid Dentifrices (-) Plaque - Lauryl sulfate found in oral hygiene products (e.g. dentifrices [147]) 
- Regular, sufficient oral hygiene (brushing teeth) prevents oral diseases like 
caries and periodontitis by removing dental plaque 
- Neglected oral hygiene results in higher plaque scores 
2,3-dihydroxyisovalerate Amino acid derivate 
(derived from BCAA 
metabolism) 
Diet (yeasts of beverages) (+) MT count - Yeast traditionally used for commercial ethanol production [148] 
- Metabolite involved in brewing beer [149] 
- Derivate of isovaleric acid (compound of hop plant, a main ingredient of beer) 





Exogenous (+) MT count - Additive to cigarettes to increase nicotine delivery in smoke and binding of 
nicotine to neural receptors  while improve application (makes smoke “softer) 
[151] 
- Smoking is the most important risk factors for periodontitis due to its toxic 
compounds and the vasoconstrictory properties (reduced immune defence 
against bacteria) 
- Smoking increases risk of early tooth loss due to periodontitis [152] 
Vanillin Xenobiotic, flavour and 
aroma compound 
Exogenous (diet) (+) MT count - Tooth loss often goes with unhealthy diet (foods with high cariogenic sugars) 
- Vanillin is one of the most important aromatics and used in beverages and foods 
that contain high amounts of sugar like chocolate, ice cream and bakery 
products 
(+) = positive association; (-) = inverse association; DF-S% = percentage of decayed or filled tooth surfaces; DF-S = total number of filled or decayed tooth surfaces; Calculus = percentage of sites with visible, 
supragingival mineralized plaque; Plaque = percentage of sites with visible, supragingival plaque; MT count = total number of missing teeth; CAL 3+mm% and CAL 4+mm% = percentage of sites with CAL ≥3/4 mm; 
Mean CAL = mean CAL over all sites; PPD 3+mm% and PPD 4+mm% = percentage of sites with PPD ≥4 mm/ 3 mm; cumPPD4+ = cumulative PPD from pockets ≥4mm; Mean PPD = mean PPD over all sites; Prosthesis/MT 
= prosthesis/missing teeth as comparison of group 1 (no prosthesis, 0-8 missing teeth) and group 3 (prosthesis, , 9-27 missing teeth); BCAA = branched-chain amino acids; ROS = reactive oxidative species; MMP = 
matrix metalloproteinase; TNF = tumor necrosis factor; IL = interleukin; SCFA = short-chain fatty acid; GCF = gingival crevicular fluid; DNA =  deoxyribonucleic acid; RNA = ribonucleic acid 
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5.2. DISCUSSION OF CORRELATION BETWEEN PLASMA AND SALIVA 
Saliva, the “mirror of the body”, is partly able to reflect physical condition of the human body 
because its composition is influenced by that of plasma.  
Plasma is the liquid component of blood and includes the essential nutrients and electrolytes 
for each cell within the human body. Additional to nutrient delivery it is also responsible for 
exchange of substances between cells and organs and clearance of metabolic end products. 
Analysis of plasma composition is an indispensable diagnostic tool in medicine which indicates 
several pathogenic circumstances and disease states. As a matter of routine plasma 
diagnostics are used to monitor and control many different diseases (e.g. diabetes, thyroid 
disease, infections, liver or kidney diseases, cancer, hormonal imbalance, and nutrient or 
vitamin deficiencies). 
Due to the fact that several plasma substances are transferred to saliva, saliva itself can be 
used as diagnostic tool instead of plasma [71-96]. In general, plasma metabolites pass into 
saliva by passive diffusion due to a concentration gradient, in which free low-molecular weight 
substances diffuse through lipid membranes or via passive transporter systems from plasma 
to saliva. This action takes place during saliva formation in the salivary glands and transport 
through the salivary duct into the oral cavity (Figure 14). Another entry for plasma compounds 
into saliva is via GCF (Figure 15), an inflammatory plasma exudate reflecting plasma 















Figure 15: Translation of blood plasma metabolites to saliva via transporter or passive 







In our study we found metabolites that demonstrably originate from plasma (e.g. creatine and 
1,5-anhydroglucitol). Therefore, we can confirm the association between plasma and saliva. 
In order to clarify the origin of the significantly with periodontitis associated saliva metabolites 
we additionally analysed the plasma metabolome of all study subjects. However, the vast 
majority of metabolites found in both fluids exhibited only moderate correlations between 
plasma and saliva in part questioning the mirror thesis (Figure 12). With respect to the present 
focus on oral phenotypes this discrepancy was even more apparent. None of the significantly 
PDD-associated salivary metabolites was either not measured in plasma or found no to be 
correlated. So, we can assume that salivary metabolome associated with periodontitis is not 








5.3. DISCUSSION OF POTENTIAL BIOMARKERS 
Several saliva metabolites, including dipeptides, amino acids and amino acid catabolites as 
well as ω-6 fatty acid metabolites, showed positive association with the assessed PPD 
variables. The deeper the periodontal pockets, and thus the more severe periodontitis, the 
more metabolites were found. Especially strong associations were observed for isovalerate, 
5-aminovalerate, N6-acetyllysine, 3-(4-hydroxyphenyl) propionate, 3-phenylpropionate 
(hydrocinnamate), phenylacetate and isocaproate. The most promising metabolite among 
them was phenylactetate, which showed consistent positive association with PPD variables 
across all age groups.  All those metabolites can be linked to protein and amino acid 
degradation as part of general tissue breakdown in periodontitis caused by microbial burden 
and host inflammation. Perhaps, they could serve as biomarkers for periodontitis and could 
be used in the development of new periodontal screening methods. Earlier intervention would 
stop disease progression and prevent extensive destruction of the periodontal supportive 
tissue and so reduce the risk of tooth loss due to periodontitis. Metabolites serving as 
biomarkers could also indicate disease severity and may be able to evaluate therapeutic 
success. As phenylacetate is found even in the young-age group it might be beneficial in early 
detection of periodontitis. 
 
5.4. STRENGTHS AND LIMITATIONS OF THE STUDY 
Our study convinces through its extraordinary huge sample size and the high-quality standards 
for all oral measurements. Several quality control mechanisms, like the biannual calibration 
and examination of the examining dentists and the use of robotics for parts of the saliva and 
plasma processing, should minimize human error and indicate high accuracy for all study data. 
Yet there are some limitations, which may have affected our results. Because of the study´s 
cross-sectional design, no causative relationship could be established. The half-mouth method 
used in SHIP for evaluation of caries and periodontal status is known to be associated with an 
underestimation of periodontal severity [155]. Despite all quality control mechanisms there is 
still the possibility of human error during oral examination or processing of saliva/plasma 
samples and thus of deviations. Food intake and the swallowing of glucose solution as part of 
oral glucose tolerance test of several subjects before saliva sampling could have affected saliva 
composition [156-158]. Last but not least our study sample only included subjects without 
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reported diabetes mellitus, which has to be considered as important risk factor for 
periodontitis [4, 159] and thus might have influenced data outcomes. 
5.5. CONCLUSION / SUMMARY 
Our comprehensive study revealed the metabolomic profile of saliva of nearly 1000 non-
diabetic subjects according to dental parameters in an age-dependent manner. Periodontitis 
seemed to have a greater influence in middle-age subjects while the number of teeth in the 
older group played a pivotal role. These findings emphasize the importance of tightly defined 
cohorts for future experimental studies. As we hypothesized, several metabolites were found 
altered in association with increased PPD and thus to periodontitis. We could also reveal that 
those changes are associated with periodontal pathogenic processes like enhanced bacterial 
metabolism, inflammation and local tissue destruction and thus confirm our second 
hypothesis. Additionally, we were able to clarify the origin of our associated metabolites 
through detailed metabolomic analysis of plasma samples of each subject and subsequent 
comparison of plasma and saliva metabolites.  
Of particular interest is phenylacetate, a bacterial catabolite of aromatic amino acids and the 
solely metabolite consistently associated with PPD parameters across all three age groups. 
This metabolite could offer the opportunity to serve as a tool in periodontal screening, 
detection of periodontal destruction and perhaps monitoring periodontal therapy. Since 
phenylacetate was already evident among young subjects it might be useful for early 
periodontal screening in young patients, who are not yet aware of any periodontal disease. 
This could be an unprecedented chance in dental care for early, purposeful intervention in the 
initial stage of periodontitis, preventing its progression to more severe stages. 
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